Evidence map›Paper›PMID 34769563›Full record

ArticleInternational journal of environmental research and public health2021

Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study.

Terry C Davis, Connie L Arnold, Glenn Mills, Glenn J Lesser, W Mark Brown, Richard Schulz, Kathryn E Weaver, Pamala A Pawloski

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Patient symptoms, confidence, and adherence during the first 8 weeks of targeted oral anticancer agent treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Terry C DavisDepartment of Medicine, Louisiana State University Health-Shreveport, Shreveport, LA 71130, USA.
Connie L ArnoldDepartment of Medicine, Louisiana State University Health-Shreveport, Shreveport, LA 71130, USA.
Glenn MillsDepartment of Medicine, Louisiana State University Health-Shreveport, Shreveport, LA 71130, USA.
Glenn J LesserDepartment of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
W Mark BrownDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.
Richard SchulzCollege of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
Kathryn E WeaverDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA.ORCID 0000-0001-9006-4064
Pamala A PawloskiMetro-Minnesota Community Oncology Research Consortium, St. Louis Park, MN 55416, USA.
Louisiana State University · USWake Forest University · USMetro-Minnesota Community Oncology Research Consortium · USUniversity of South Carolina · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Wake Forest NCORP Research BaseUG1CA189824 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Emily Van Meter Dressler, GLENN J LESSER · 2014 to 2026
$57.9M
Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)UG1CA189854 · NCI · LSU HEALTH SCIENCES CENTER · PI AUGUSTO C. OCHOA · 2014 to 2026
$27.1M
NCI NIH HHS 1UG1CA189824NCI NIH HHS 2UG1CA189854NCI NIH HHS UG1 CA189854NIGMS NIH HHS 2 U54 GM104940-02NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

The purpose of this pilot study was to assess Chronic Myeloid Leukemia (CML) patients' adherence to, beliefs about, and barriers to oral anticancer agents (OAC) using brief self-report measures in community-based cancer clinics. Patients completed a structured interview including a health literacy assessment, a Brief Medication Questionnaire, two single-item self-report adherence questions, and the Medications Adherence Reasons Scale. Of the 86 participants, 88.4% were white; 55.8% male; mean age, 58.7 years; and 22.1% had limited health literacy. Nonadherence (missing at least one dose in the last week) was reported by 18.6% of participants and associated (

Indexed as

Antineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAdministration, OralFemaleHumansMaleMedication AdherenceMiddle AgedPilot ProjectsAntineoplastic Agentsantineoplastic agentschronic myelogenous leukemiahealth literacymedication adherenceself-report

Identifiers

PMID34769563
PMCPMC8582838
OpenAlexW3210527282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.